RMB. I'll let U know ( actually price action will show it ) ...when they have this final trial fully enrolled https://investors.soleno.life/news-releases/news-release-details/soleno-therapeutics-announces-initiation-randomized-withdrawal So they have to persuade 80 patients currently in their long term study to drop out and enroll in this trial . This may be hard to do.... as those in this ongoing long term study are probably staying on the drug as they have seen benefits ( note photos in Co presentations ) . So at some pt they may have to say they are discontinuing providing the drug to all ...until the trial is fully enrolled. Other notes 29% of Aussies are obese vs 36% in the US 6% of Aussies have diabetes vs 11% in the US Am moving back into SWAV as demand for their product is still strong. China will open up once this Covid wave pass's there ( They have an approved Chinese partner ) and valuation is now a lot better. ETNB currently one of my largest biotechs ..data in Q1 Good luck Kiwi
RMB They almost have this fully enrolled ( UK was slow in approving the trial ). Once fully enrolled they get a $10m cash infusion . Trial ( once fully enrolled ) only lasts 4 mths . High risk but potentially high reward. ......an opinion , NOT a recommendation :--) Kiwi
Perceptive Advisors Llc ownership in US8342033094 / SOLENO THERAPEUTICS INC
2023-05-18 - Perceptive Advisors Llc has filed an SC 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,864,455 shares of SOLENO THERAPEUTICS INC (US:US8342033094). This represents 22.8 percent ownership of the company.
News 
Market Data 
Discover 
